Longer-term follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE

被引：0
|
作者：
Marantz, J. [1 ]
Gold, R. [2 ]
Giovannoni, G. [3 ]
Phillips, J. T. [4 ]
Fox, R. J. [5 ]
Zhang, A. [1 ]
机构：
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[3] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[4] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[5] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P564
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [41] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    JOURNAL OF NEUROLOGY, 2014, 261 : S306 - S306
  • [42] Delayed-release dimethyl fumarate and health-related quality of life (HRQoL) in relapsing-remitting multiple sclerosis (RRMS) patients according to prior therapy: integrated analysis of DEFINE and CONFIRM
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Kita, M.
    Phillips, J. T.
    Sarda, S. P.
    Zhong, L.
    Niecko, T.
    Kurukulasuriya, N. C.
    Giovannoni, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 462 - 462
  • [43] Long-term follow-up of the effect of delayed-release dimethyl fumarate on No Evidence of Disease Activity in patients with multiple sclerosis
    Giovannoni, G.
    Havrdova, E.
    Gold, R.
    Fox, R. J.
    Kappos, L.
    Phillips, J. T.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 479 - 479
  • [44] Long-term follow-up of the effect of delayed-release dimethyl fumarate on no evident disease activity in patients with multiple sclerosis
    Giovannoni, G.
    Gold, R.
    Fox, R. J.
    Kappos, L.
    Phillips, T.
    Zhang, A.
    Kurukulasuriya, N. C.
    Havrdova, E.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 44 - 45
  • [45] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis using a composite measure of disability: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Phillips, J. T.
    Giovannoni, G.
    Kappos, L.
    Havrdova, E.
    Hutchinson, M.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 303 - 304
  • [46] 3-Year Follow-up of Oral BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Clinical Outcomes from the DEFINE, CONFIRM, and ENDORSE Studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Rana, J.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 932 - 932
  • [47] Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
    Gold R.
    Giovannoni G.
    Phillips J.T.
    Fox R.J.
    Zhang A.
    Marantz J.L.
    Neurology and Therapy, 2016, 5 (1) : 45 - 57
  • [48] Effect of BG-12 (dimethyl fumarate) in newly diagnosed relapsing remitting multiple sclerosis (RRMS) patients from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 453 - 454
  • [49] Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Hutchinson, Michael
    Kappos, Ludwig
    Havrdova, Eva
    MacManus, David G.
    Yousry, Tarek A.
    Pozzilli, Carlo
    Selmaj, Krysztof
    Sweetser, Marianne T.
    Zhang, Ray
    Yang, Minhua
    Potts, James
    Novas, Mark
    Miller, David H.
    Kurukulasuriya, Nuwan C.
    Fox, Robert J.
    Phillips, Theodore J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 253 - 265
  • [50] Efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients with moderate disability: an integrated analysis of the phase 3 studies
    Hutchinson, M.
    Zhang, A.
    Yang, M.
    Okwuokenye, M.
    Kurukulasuriya, N. C.
    Fox, R. J.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 116 - 116
12345